已发表论文

慢性阻塞性肺疾病合并肺结核患者血清炎症因子水平变化与疾病严重程度的相关性

 

Authors Di Y, Yang F, Che C, Xu S, Qi Y

Received 12 February 2025

Accepted for publication 29 May 2025

Published 28 June 2025 Volume 2025:18 Pages 3547—3556

DOI https://doi.org/10.2147/IJGM.S522251

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Héctor M. Mora-Montes

Yiyao Di,1,* Fan Yang,2,* Conglu Che,3 Shenghui Xu,4 Ying Qi3 

1Respiratory Department, Affiliated Hospital of Hebei University, Baoding, Hebei, People’s Republic of China; 2Emergency Department II, Baoding First Central Hospital, Baoding, Hebei, People’s Republic of China; 3Tuberculosis Department, Affiliated Hospital of Hebei University, Baoding, Hebei, People’s Republic of China; 4Tuberculosis Department, Second Hospital of Shijiazhuang, Shijiazhuang, Hebei, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Conglu Che, Tuberculosis Department, Affiliated Hospital of Hebei University, 212 Yuhua East Road, Lianchi District, Baoding, Hebei, 071000, People’s Republic of China, Email checonglu2019@163.com

Background: The coexistence of chronic obstructive pulmonary disease (COPD) and tuberculosis (TB) complicates diagnosis and treatment, increasing disease burden and mortality. The correlation between serum inflammatory factors and disease severity and prognosis in COPD patients with TB remains unclear.
Methods: This retrospective study included 200 participants treated at the Affiliated Hospital of Hebei University from December 2020 to December 2022: 80 patients with COPD and TB, 40 with COPD alone, 40 with TB alone, and 40 healthy controls. Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interferon-γ (IFN-γ), soluble IL-2 receptor (sIL-2R), and C-reactive protein (CRP) were compared across groups and correlated with disease severity and prognosis in COPD patients with TB.
Results: Serum levels of TNF-α, IL-6, IFN-γ, sIL-2R, and CRP were significantly higher in the COPD with TB group compared to all other groups (P< 0.05). In this group, elevated levels of these markers were associated with increased disease severity and poorer prognosis (P< 0.05). Correlation analysis showed positive associations between inflammatory cytokine levels and disease severity, and negative associations with prognosis (P< 0.05).
Conclusion: Serum inflammatory markers may help assess disease severity and prognosis in COPD patients with TB. However, due to the observational design, causality cannot be inferred. Further prospective, multi-center studies are required to validate these findings before clinical application.

Keywords: chronic obstructive pulmonary disease, tuberculosis, inflammatory factors, disease condition, prognosis